Top Markets
Coin of the day
Prince Pharmaceutical Co., Ltd. Prince Pharmaceutical Co., Ltd.

Prince Pharmaceutical Co., Ltd.

6935
Rang in Aktien #27309
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of... Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.
Aktienkurs
$0.89991249
Marktkapitalisierung
$33.67M
Veränderung (1 Tag)
-0.35%
Veränderung (1 Jahr)
7.33%
Land
TW
Handel Prince Pharmaceutical Co., Ltd. (6935)

Kategorie

Aktien-Split-Historie für Prince Pharmaceutical Co., Ltd. (6935)
Die Aktie Prince Pharmaceutical Co., Ltd. (Symbol: 6935) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 20, 2026 statt.
Eine 6935-Aktie, die vor dem Aug 20, 2026 gekauft wurde, entspricht heute 0 6935-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber